Cartilage has poor regenerative capacity. Donor site morbidity and interference with joint homeostasis should be considered when applying the autologous chondrocyte transplantation technique. The use of ectopically produced cartilage, derived from periosteum, might be a novel method to heal cartilage defects. Ectopic cartilage was produced by dissecting a piece of periosteum from the tibia of rabbits. After 14 days the reactive tissue at the dissection site was harvested and a graft was cored out and press-fit implanted in an osteochondral defect in the medial condyle of the femur with or without addition of hyaluronan. After 3 weeks and 3 months the repair reaction was evaluated by histology. Thionine-and collagen type II-stained sections were evaluated for graft viability, ingrowth of the graft, and joint surface repair. Empty defects remained empty 3 weeks after implantation, ectopic cartilage filled the defect to the level of the surrounding cartilage. Histologically, the grafts were viable, consisting mainly of cartilage, and showed a variable pattern of ingrowth. Three months after implantation empty defects with or without hyaluronan were filled primarily with fibrocartilaginous tissue. Defects treated with ectopic cartilage contained mixtures of fibrocartilaginous and hyaline cartilage. Sometimes a tidemark was observed in the new articular cartilage and the orientation of the cells resembled that of healthy articular cartilage. Subchondral bone repair was excellent. The modified O'Driscoll scores for empty defects without and with hyaluronan were 12.7 ؎ 6.4 and 15.3 ؎ 3.2; for treated defects scores were better (15.4 ؎ 3.9 and 18.2 ؎ 2.9). In this conceptual study the use of ectopic cartilage derived from periosteum appears to be a promising novel method for joint surface repair in rabbits.
INTRODUCTION
A RTICULAR CARTILAGE has a limited capacity for repair. Injured articular surfaces are generally thought to progress toward premature osteoarthritis (OA). 1 Osteoarthritis is an invalidating disease that hampers daily life activities and is a substantial health care burden.
Research has been focused on repair of articular surfaces by tissue-engineering methods. Various treatment modalities are currently available, such as autologous perichondrium transplantation, 2-5 debridement combined with microfracture or subchondral drilling, [6] [7] [8] mosaicplasty, 9, 10 and autologous chondrocyte transplantation (ACT). 11 All these methods have their drawbacks: fixation of the graft was a major problem in perichondrium transplantations 12 ; this has been resolved by changes in the operation technique (S.K. Bulstra, unpublished data). Microfracture or subchondral drilling procedures have been shown to produce repair tissue that is fibrocartilaginous, although significant symptomatic relief has been obtained. Mosaicplasty requires harvesting of osteochondral plugs from less weight-bearing sites of the affected joint, and the fate of the donor sites is unclear. There are experimental indications that damaged cartilage, also in less weight-bearing sites, will result in OA. 13 ACT also requires harvesting of cartilage from a less weight-bearing site of the affected joint. Other drawbacks of the latter procedure are the costs and safety requirements of the cell culture procedure that is part of this method. In a randomized trial comparing ACT with the microfracture technique, no clinical differences were found at 2 years of follow-up. 14 Hyaluronan (HYA) is known to be chondroprotective, to prevent apoptosis via the CD44 receptor, and has even been reported to enhance cartilage repair. Therefore HYA may contribute to the cartilage repair techniques mentioned above. 15 We discovered that under certain conditions, dissecting a piece of periosteum from the proximal tibia resulted in the formation of ectopic cartilage, which in time gradually transformed into bone. 16 The ectopic cartilage contained collagen type II fibers and the expressions of collagen type II and aggrecan genes was upregulated 10 and 20 days postinduction. Collagen type I was present at 10 days, but could no longer be detected at 20 days postinduction in the cartilaginous tissue. 16 A similar form of periosteum-derived cartilage tissue engineering has previously been described by Stevens et al. 17 In the present study we induced ectopic cartilage in rabbits and transplanted the tissue 14 days after induction into osteochondral defects in the same animals (autologous procedure) with or without additional hyaluronan. 15, [18] [19] [20] [21] Graft ingrowth and viability were examined at 3 weeks. Repair of the joint surface was evaluated at 3 months postimplantation.
MATERIALS AND METHODS

Surgical procedures
Six-month-old female New Zealand White rabbits were used for this study. European and Dutch laws on animal experimentation were strictly followed throughout the study and the experimental animal protocol was approved by the Maastricht University committee for animal experiments. Surgical procedures were performed under general anesthesia and using strictly aseptic techniques. Anesthetic induction was obtained with ketamine hydrochloride (35 mg/kg) and xylazine hydrochloride (5 mg/kg) administered by intramuscular injection. Anesthesia was maintained by means of a mixture of 2% isoflurane and oxygen delivered by an automatic venti-EMANS ET AL.
lator equipped with a specially designed mask. Preoperatively all rabbits received an intramuscular injection of antibiotics (ceftiofur sodium, 10 mg/kg; Pharmacia & Upjohn, Woerden, The Netherlands). Postoperative painkilling was done by administering buphenorphine (0.05 mg/kg) intramuscularly each day for 2 days. Both hindlegs of the rabbits were treated.
The skin was opened at the medial side of the knee and upper medial side of the tibia. The knee joint was opened medially; an incision of the patellar tendon was made along its length. A cartilage-only defect, 3 mm in diameter, was made on the medial condyle, using a sharp dermal biopsy punch. The rationale for this was that this animal model more closely resembles the clinical situation, in which patients with isolated articular cartilage defects are operated on weeks to months after the trauma causing the defect has occurred. 12 The model will be described elsewhere. 22 The knee was closed with Polysorb 2.0 (Tyco Healthcare/U.S. Surgical, Norwalk, CT).
Hereafter an incision perpendicular to the fascia of the pes anserinus was made in order to access the underlying periosteum. A periosteal defect of approximately 6 ϫ 12 mm was created. The fascia and the pes anserinus were sutured with Polysorb 2.0. With special care, the tendon of the semitendinosus muscle was sutured on top of the distal, short side of the periosteal defect. Hereafter the skin was closed with Polysorb 4.0 (Tyco Healthcare/U.S. Surgical). Fourteen days after the first operation, the rabbits were anesthetized and the knee was accessed as described above. The reactive tissue, cartilage out of periosteum (COP), was dissected with a scalpel. A construct with a diameter of 3 mm was cored out with a sharp dermal biopsy punch (Fig. 1A) . The overlying fibrous tissue was dissected from the construct and the thickness of the construct was measured. The cartilage defect on the medial condyle was extended to an osteochondral defect of the same depth as the thickness of the construct, using a bore with a diameter of 3 mm. The constructs were press-fit implanted (Fig. 1B) . Osteochondral defects were treated as follows: (1) left empty (empty group), (2) received a drop of hyaluronan (HYA) (Ostenil; Chemedica, Munich, Germany) and after closure the knee was injected with 1 mL of HYA (empty plus HYA group), (3) press-fit filled with ectopic cartilage (EC group), or (4) treated with a drop of HYA in which the ectopic cartilage was press-fit implanted and after closure the joint was injected with 1 mL of HYA (EC plus HYA group). Again the overlying fascias, joint, and skin were closed with Polysorb sutures (Tyco Healthcare/U.S. Surgical). After 3 weeks and 3 months the rabbits were killed by cervical dislocation or with an overdose of pentobarbital. The femoral condyles were harvested and fixed in 4% paraformaldehyde.
Staining protocols
After decalcification in EDTA the condyles were dissected into two pieces and dehydrated in a series of increasing concentrations of ethanol. Half were embedded in glycidyl methacrylate (GMA) (Technovit 7100; Heraeus Kulzer, Wehrheim, Germany), and the other half were embedded in paraffin. Five-micrometer sections were cut, and the GMA sections were stained with thionine or with hematoxylin and eosin (H&E). Cell and nuclear morphology were judged by an experienced pathobiologist in order to determine cell and tissue viability (subjective and qualitative). The modified O'Driscoll score (maximum score, 27) 23 for cartilage repair was used to evaluate the quality of cartilage repair. [24] [25] [26] Two observers blinded to sample codes scored the sections independently. Because the differences between empty defects and treated defects were obvious, the observers were blinded only for the addition of HYA. Also, the extent of subchondral bone repair was scored as level, incomplete, or protruding.
For immunohistochemical staining of collagen type II, sections were dewaxed and hydrated according to standard protocols. The sections were then pretreated with OSTEOCHONDRAL REPAIR WITH ECTOPICALLY PRODUCED CARTILAGE 1% hyaluronidase (30 min, 37°C) and 0.2% Pronase (30 min at 37°C) and a 1:50 dilution of primary antibody solution (mouse monoclonal anti-collagen type II, II-II6B3; Developmental Studies Hybridoma Bank [DSHB], Iowa City, IA) was applied. After overnight incubation with the primary antibody at room temperature, sections were washed with phosphate-buffered saline (PBS) and incubated with the secondary antibody, horseradish peroxidase (HRP)-conjugated rabbit anti-mouse IgG (ITK Diagnostics, Uithoorn, The Netherlands). Subsequently, sections were washed with PBS and incubated with avidin-biotin complex conjugated with HRP. Diaminobenzidine (DAB) was used as a substrate for peroxidase. The sections were then counterstained with hematoxylin and dried, and coverslips were applied.
Statistical analyses
The Mann-Whitney U test with a Hochberg post hoc correction test was used for statistical analysis of the modified O'Driscoll scores. The significance level was set at p Ͻ 0.05. The 2 test at p Ͻ 0.05 was used to analyze the level of subchondral bone repair. 
RESULTS
Observations and macroscopic impression
At the second operation ectopic cartilage production was found in 93% of cases by macroscopic and histological examination (see also Emans et al. 16 ). The average thickness of the generated constructs was 2.05 Ϯ 0.39 mm (n ϭ 38). During the first week after the second operation, it was observed that the rabbits limped, favoring the leg in which the defect was left empty. This was not observed if the defect was treated with COP.
Macroscopic examination revealed that after 3 weeks the empty defects, both with (n ϭ 4) and without (n ϭ 5) HYA, were far from completely filled (Fig. 2A) . In contrast, at EMANS ET AL.
this time all defects treated with an ectopic cartilage graft both with (n ϭ 7) and without (n ϭ 8) HYA were filled to the level of the surrounding cartilage (Fig. 2B) .
After 3 months two of the empty osteochondral defects were still not filled completely. At this time none of the osteochondral defects treated with ectopic cartilage grafts (with HYA [n ϭ 10] or without HYA [n ϭ 8]) showed gross defects.
Histology and cartilage repair score
After 3 weeks, some fibrin formation, fibroblasts, and macrophages were observed in the empty defects both with and without HYA (Fig. 3A and C) . The first signs of a primary osteogenic repair reaction were visible. The implanted grafts had a viable appearance, consisted mainly of cartilage, and showed good ingrowth in the majority of cases ( Fig. 3B and D) .
After 3 months of follow-up the empty defects were partially filled with fibrous or fibrocartilaginous tissue (Fig.  4A) . The modified O'Driscoll scores for the groups of empty defects without and with HYA were 12.7 Ϯ 6.4 and 15.3 Ϯ 3.2, respectively. Defects treated with ectopic cartilage grafts revealed restoration, with fibrocartilaginous tissue up to level of the surrounding cartilage and good integration with the existing cartilage (Fig. 4B) . Pathologically, the repair tissues in all treated defects were completely viable. In some cases the new articular cartilage appeared to have a tidemark and the orientation of the cells was similar to that of healthy articular cartilage (Fig. 4C  and D) . The cells were rounded in the radial and deep zones of the cartilage and flattened at the superficial layer. The number of cells was higher than in the adjacent recipient cartilage. The modified O'Driscoll scores for the groups OSTEOCHONDRAL REPAIR WITH ECTOPICALLY PRODUCED CARTILAGE treated with ectopic cartilage grafts without and with HYA were 15.4 Ϯ 3.9 and 18.2 Ϯ 2.9, respectively. The differences between the two groups with empty defects, with or without HYA, and the group with treated defects plus HYA were significant, p Ͻ 0.02 (Fig. 5) . HYA alone did not significantly enhance cartilage repair compared with the empty control.
Remarkable was the good subchondral bone repair in almost all cases. In four cases bone growth was protruding into areas where normally articular cartilage would be present: two empty defects, one empty plus HYA defect, and one treated plus HYA defect (Fig. 6 ). There was no significant difference in subchondral bone repair between the empty defects and the ectopic cartilage-treated defects. However, there was a significant difference between defects treated with HYA and defects not treated with HYA: with HYA in 61.1% (11 of 18) of the defects subchondral bone repair was scored as level, without HYA this was 45.5% (5 of 11) (p Ͻ 0.01). 
Immunohistochemical staining
Three weeks after implantation the graft remained positive for collagen type II (Fig. 3E) . Some collagen type II was visible at the bottom of the empty defect. Three months after transplantation collagen type II staining was seen in all osteochondral defects treated with ectopic cartilage (Fig. 3F) . The repair tissue formed if the defect was left empty also showed positive collagen type II staining in most cases. Overall, no large differences in collagen type II staining could be detected between the empty and treated groups.
DISCUSSION
This is a conceptual study in which we illustrate that it is possible to produce cartilaginous tissue at an ectopic location in a rabbit and to use this tissue to fill and repair an osteochondral defect in the knee joint of the same animal. This is a novel mode of tissue engineering, in which cell isolation and culture in a laboratory are no longer necessary.
This study was performed in 6-month-old rabbits, which are still young and skeletally hardly mature. The age of the animal or patient may be important in determining the success rate of the cartilage induction procedure, because the number of cambial layer cells in periosteum, which are suggested to form the cartilaginous tissue, rapidly decreases with age. 27, 28 However, two studies showed that it is possible to stimulate periosteal cells from patients 70 years of age and older to differentiate into the chondrogenic lineage. 29, 30 Induction of ectopic cartilage by dissecting a piece of periosteum was successful in 93% of cases. Although this is already a high number, in order to use this procedure in the clinic a success rate close to 100% may be necessary. This may be achieved by optimizing the method of EMANS ET AL. induction of ectopic cartilage. Other ways to stimulate periosteal cells to proliferate and differentiate have been explored 17, 31 and may result in higher success rates and more reproducible, high-quality tissue. Also, during the operation to induce cartilage formation an arthrotomy was performed to produce a cartilage-only defect and factors from the synovial fluid may affect the induction of ectopic cartilage. Positive effects of HYA and synovial fluid on the differentiation of mesenchymal "stem" cells from bone marrow have been described. 32 The thickness of the ectopic cartilage at 14 days postinduction was 2.05 mm, which is quite sufficient to repair rabbit articular cartilage, which is 120-200 m thick. The thickness of human articular cartilage is 2-6 mm, so in order to repair human articular cartilage defects thicker ectopic cartilage needs to be induced.
Treatment of osteochondral defects with ectopic cartilage reduced the frequency at which animals limped. This indicates a significant reduction in experienced pain. Whether filling of the defect also reduces degeneration of the edges of the original cartilage will depend on the quality of the grafted tissue; in order to do so, the mechanical properties of the grafted tissue should be comparable to those of the original cartilage. However, the chance that degeneration will be less is much higher than with methods in which tissue must grow in situ, such as ACT, perichondrium transplantation, and periosteum transplantation.
Histologically, the grafted tissue maintained its viability both at 3 weeks and at 3 months postimplantation. This is in contrast to tissue-engineered cartilage, in which cell viability gradually decreased. 33 The repair tissue in the osteochondral defect had many aspects of hyaline cartilage. All the grafted tissues stained positive with antibodies for collagen type II at 3 weeks and 3 months of follow-up. Next, at 3 months of follow- up, in most cases proper orientation of chondrocytes was also observed, and sometimes even a tidemark.
The addition of HYA in general improved the repair reaction. The results for empty defects treated with HYA were as good as those of ectopic cartilage-treated defects without HYA at 3 months of follow-up. The quality of the repair as assessed by modified O'Driscoll score was again better when HYA was added to ectopic cartilagetreated defects. The differences were small and can be attributed to the observed effect of HYA on subchondral bone repair, because subchondral bone repair is an intrinsic part of the score. The positive effect of HYA on the subchondral bone repair reaction was unforeseen. Protective effects of HYA on chondrocytes have been described and that was why HYA was tested in these repair reactions. 15 It is possible that HYA also functions in the control of the hypertrophic differentiation of chondrocytes and subsequent subchondral bone growth. Further research will be needed to elucidate this effect of HYA and to determine whether addition of HYA may be an alternative for administration of indomethacin, which has been shown to inhibit (prevent) bone protrusion in clinical articular cartilage repair procedures. 12, 34 An important issue that should also be mentioned here is the change of chondrocytes from transient cells (ectopic cartilage, which transforms into bone in 40 days) to permanent cells (hyaline cartilage at the repair site at 3 months of follow-up). This process, which occurs in embryos, is not well understood. Whether tenascin-C, which is a marker for permanent cells, and the transcription factors Runx-2 and C-1-1 play a role in this process needs to be elucidated. [35] [36] [37] [38] In considering this phenomenon, it was interesting to note that 35 days (14 days at transplantation plus 21 days [3-week evaluation]) after induction the implant remained largely in its chondrogenic phase as seen by thionine staining and collagen type II staining. In contrast, reactive periosteal tissue is completely transformed into bone after 40 days if left at the site of induction. 16 The described procedure of repair of an osteochondral defect with ectopically produced cartilage has several advantages over the tissue-engineering methods currently used in the clinic. First, there is no need to harvest cartilage from the affected joint, so in this joint there will be no donor site morbidity. Second, the time span between induction and transplantation of ectopic cartilage was 14 days (in rabbits). This is relatively short compared with the time needed to isolate, expand, and seed chondrocytes from harvested cartilage. These procedures are prone to mistakes and infections and require a number of safety requirements, which make them expensive. Using the patient's own body as a cartilage-generating reactor eliminates all these issues and may evolve into an inexpensive and versatile way to produce cartilage for articular surface repair.
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